Japan to India: Vati Import Trade Route
India has recorded 12 verified shipments of Vati imported from Japan, representing a combined trade value of $1.2M USD. This corridor is served by 3 active Japan exporters, with an average shipment value of $98.1K USD. The leading Japan supplier is EISAI CO. LTD. , which accounts for 43% of total import value with 6 shipments worth $505.7K USD. On the buying side, EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED is the largest Indian importer with $930.4K USD in purchases. The top 3 suppliers — EISAI CO. LTD. , EISAI CO. LTD., EISAI CO. LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.

Route Intelligence Overview
The Japan to India Vati corridor is one of India's established pharmaceutical import routes from Japan, with 12 shipments documented worth a combined $1.2M USD. The route is dominated by EISAI CO. LTD. , which alone accounts for roughly 43% of all import value, reflecting the consolidated nature of Japan's vati export sector.
Across 3 active Japan suppliers, the average shipment value stands at $98.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with vati's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 14.1%, placing it at rank #17 among India's top vati import origins globally.
On the Indian buyer side, key Indian importers include EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED , EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED. EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED is the single largest Indian importer with 9 shipments valued at $930.4K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ1
- Primary modeSea freight
- Top port of entryN?A
Market Position
- Global rank#17
- Annual growth+14.1%
- Demand growth+14.2%
- Regulatory ease77/100
Top 10 Vati Exporters from Japan to India
Showing top 10 of 3 Japan suppliers exporting Vati to India, ranked by total trade value (USD)
| Rank | Supplier (Japan Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EISAI CO. LTD. Avg $84.3K per shipment | 6 | $505.7K | 43.0% |
| 2 | EISAI CO. LTD. Avg $87.6K per shipment | 5 | $438.1K | 37.2% |
| 3 | EISAI CO. LIMITED Avg $232.8K per shipment | 1 | $232.8K | 19.8% |
This table shows the top 10 of 3 Japan companies exporting vati to India, ranked by total trade value. The listed exporters are: EISAI CO. LTD. , EISAI CO. LTD., EISAI CO. LIMITED . EISAI CO. LTD. is the dominant supplier with 6 shipments worth $505.7K USD, giving it a 43% market share.
Top 10 Indian Vati Importers from Japan
Showing top 10 of 2 known Indian buyers receiving Vati shipments from Japan, ranked by import value
On the receiving end of this trade route, the leading Indian importers of Japan vati include EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED , EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED. The largest importer is EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED , accounting for $930.4K USD across 9 shipments — representing 79% of all vati imports from Japan on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED | 9 | $930.4K | 79.1% |
| 2 | EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED | 3 | $246.2K | 20.9% |
Top 10 Vati Formulations Imported from Japan
Showing top 10 of 11 product formulations shipped on the Japan to India Vati route, ranked by trade value
India imports a wide range of vati formulations from Japan, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LENVATINIB CAPSULES 4MG 10CAPS/BLISTER2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.143394 (7960 BOXES) — accounts for $232.8K USD across 1 shipments. There are 11 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LENVATINIB CAPSULES 4MG 10CAPS/BLISTER2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.143394 (7960 BOXES) | 1 | $232.8K | 19.8% |
| 2 | LENVATINIB CAPSULES 4MG, 10CAPS/BLISTER,2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.138721 (5900 BOXES) | 1 | $174.4K | 14.8% |
| 3 | LENVATINIB CAPSULES 4MG, 10CAPS/BLISTER,2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.141649 (4660 BOXES) | 1 | $147.4K | 12.5% |
| 4 | LENVATINIB CAPSULES 4MG (PAP),10CAPS/BLISTER 2BLISTERS(20CAPS)/BOX (LOT NO. 145217) | 1 | $136.7K | 11.6% |
| 5 | LENVATINIB CAPSULES 10MG, 10CAPS/BLISTER,2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.138525 (2700 BOXES) | 1 | $116.1K | 9.9% |
| 6 | LENVATINIB CAPSULES 4MG, 10CAPS/BLISTER,2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.29A02K/29A04K (3109 BOXES) | 1 | $91.8K | 7.8% |
| 7 | LENVATINIB CAPSULES 10MG, 10CAPS/BLISTER,2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.144135 (1900 BOXES) JPY | 1 | $82.6K | 7.0% |
| 8 | LENVATINIB CAPSULES 10MG, 10CAPS/BLISTER,2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.141394 (1320 BOXES) | 1 | $60.7K | 5.2% |
| 9 | LENVATINIB CAPSULES 10MG (PAP),10CAPS/BLISTER 2BLISTERS(20CAPS)/BOX (LOT NO. 145353) | 1 | $55.1K | 4.7% |
| 10 | LENVATINIB CAPSULES 10MG, 10CAPS/BLISTER,2BLISTERS (20CAPS)/BOX (LENVIMA) LOT NO.29A03K (459 BOXES) | 2 | $40.9K | 3.5% |
Showing top 10 of 11 Vati formulations imported from Japan on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
N?A handles the highest volume with 5 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's vati imports from Japan are driven primarily by a handful of large-scale Japan manufacturers. EISAI CO. LTD. with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from Japan supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EISAI CO. LTD. , EISAI CO. LTD., EISAI CO. LIMITED — together account for 100% of total trade value on this route. The average shipment value of $98.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lenvatinib capsules 4mg, 10caps/blister,2blisters (20caps)/box (lenvima) lot no.138721 (5900 boxes) and lenvatinib capsules 4mg, 10caps/blister,2blisters (20caps)/box (lenvima) lot no.141649 (4660 boxes) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Japan supplier.
On the buying side, EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED is the largest importer with 9 shipments worth $930.4K USD — representing 79% of all vati imports from Japan on this route.
Route Statistics
- Trade Volume
- $1.2M
- Avg. Shipment
- $98.1K
- Suppliers
- 3
- Buyers
- 2
- Transit (Sea)
- ~20 days
- Annual Growth
- +14.1%
Unlock the Full Japan to India Vati Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 12 shipments on this route.
Frequently Asked Questions — Japan to India Vati Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Japan companies export Vati to India?
The leading Japan exporters of Vati to India are EISAI CO. LTD. , EISAI CO. LTD., EISAI CO. LIMITED . EISAI CO. LTD. holds the largest market share at approximately 43% of total trade value on this route.
Q What is the total value of Vati imports from Japan to India?
India imports Vati from Japan worth approximately $1.2M USD across 12 recorded shipments. The average value per shipment is $98.1K USD.
Q Which Indian ports receive Vati from Japan?
The most active Indian port of entry is N?A with 5 shipments. Japan exporters primarily use sea freight for this route, with 75% of shipments going by sea and 22% by air.
Q How long does shipping take from Japan to India for Vati?
The average transit time for Vati shipments from Japan to India is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the Japan to India Vati import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 14.1% with demand growth tracking at 14.2%. The route is ranked #17 among India's top Vati import origins globally.
Q How many Japan suppliers are active on this Vati import route?
There are currently 3 active Japan suppliers exporting Vati to India. The market is moderately concentrated with EISAI CO. LTD. accounting for 43% of total shipment value.
Q Who are the main Indian importers of Vati from Japan?
The leading Indian importers of Vati from Japan include EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED , EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED. EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED is the largest buyer with 9 shipments worth $930.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Japan export trade corridor identified from Indian Customs (DGFT) records for Vati.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 2 importers in Japan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 12 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists